Rhizopus oryzae is a Intradermal; Percutaneous; Subcutaneous Solution in the Non-standardized Allergenic category. It is labeled and distributed by Greer Laboratories, Inc.. The primary component is Rhizopus Arrhizus.
Product ID | 22840-5633_77436178-2957-6a77-e053-2a91aa0a873e |
NDC | 22840-5633 |
Product Type | Non-standardized Allergenic |
Proprietary Name | Rhizopus oryzae |
Generic Name | Rhizopus Oryzae |
Dosage Form | Solution |
Route of Administration | INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS |
Marketing Start Date | 1981-09-15 |
Marketing Category | BLA / BLA |
Application Number | BLA101833 |
Labeler Name | Greer Laboratories, Inc. |
Substance Name | RHIZOPUS ARRHIZUS |
Active Ingredient Strength | 0 g/mL |
Pharm Classes | Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 1981-09-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA101833 |
Product Type | NON-STANDARDIZED ALLERGENIC |
Marketing Start Date | 1981-09-15 |
Ingredient | Strength |
---|---|
RHIZOPUS ARRHIZUS | .05 g/mL |
NDC | Brand Name | Generic Name |
---|---|---|
22840-2619 | Rhizopus oryzae | Rhizopus oryzae |
22840-2620 | Rhizopus oryzae | Rhizopus oryzae |
22840-2621 | Rhizopus oryzae | Rhizopus oryzae |
22840-5633 | Rhizopus oryzae | Rhizopus oryzae |
36987-2073 | Rhizopus oryzae | Rhizopus oryzae |
36987-2074 | Rhizopus oryzae | Rhizopus oryzae |
36987-2075 | Rhizopus oryzae | Rhizopus oryzae |
36987-2076 | Rhizopus oryzae | Rhizopus oryzae |
36987-2077 | Rhizopus oryzae | Rhizopus oryzae |
36987-2078 | Rhizopus oryzae | Rhizopus oryzae |
36987-2079 | Rhizopus oryzae | Rhizopus oryzae |
36987-2080 | Rhizopus oryzae | Rhizopus oryzae |
36987-2081 | Rhizopus oryzae | Rhizopus oryzae |
49643-118 | Rhizopus | Rhizopus oryzae |